These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 10649243

  • 1. Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma.
    Koda M, Murawaki Y, Mitsuda A, Ohyama K, Horie Y, Suou T, Kawasaki H, Ikawa S.
    Cancer; 2000 Feb 01; 88(3):529-37. PubMed ID: 10649243
    [Abstract] [Full Text] [Related]

  • 2. Combination therapy of percutaneous mitoxantrone injection, percutaneous ethanol injection, and transcatheter arterial embolization for intrahepatic hepatocellular carcinoma and adrenal metastasis.
    Kiba T, Numata K, Kitamura T, Morita K, Saito S, Sekihara H.
    Hepatogastroenterology; 2001 Feb 01; 48(38):427-31. PubMed ID: 11379324
    [Abstract] [Full Text] [Related]

  • 3. Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection.
    Ishii H, Okada S, Nose H, Okusaka T, Yoshimori M, Takayama T, Kosuge T, Yamasaki S, Sakamoto M, Hirohashi S.
    Cancer; 1996 May 01; 77(9):1792-6. PubMed ID: 8646676
    [Abstract] [Full Text] [Related]

  • 4. Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection.
    Khan KN, Yatsuhashi H, Yamasaki K, Yamasaki M, Inoue O, Koga M, Yano M.
    J Hepatol; 2000 Feb 01; 32(2):269-78. PubMed ID: 10707867
    [Abstract] [Full Text] [Related]

  • 5. Predictive factors of survival and intrahepatic recurrence of hepatocellular carcinoma in cirrhosis after percutaneous ethanol injection: analysis of 71 patients.
    Castellano L, Calandra M, Del Vecchio Blanco C, de Sio I.
    J Hepatol; 1997 Nov 01; 27(5):862-70. PubMed ID: 9382974
    [Abstract] [Full Text] [Related]

  • 6. Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.
    Chung GE, Kim W, Lee JH, Kim YJ, Yoon JH, Lee JM, Lee JY, Kim SH, Kim D, Lee HS.
    J Gastroenterol Hepatol; 2011 Nov 01; 26(11):1638-45. PubMed ID: 22011297
    [Abstract] [Full Text] [Related]

  • 7. Usefulness of tumor pressure as a prognostic factor in cases of hepatocellular carcinoma where the diameter of the tumor is 3 cm or less.
    Ueki T, Sakaguchi S, Miyajima Y, Hatono N, Tohara K, Nakabayashi S, Yao T, Kokawa H, Hirano M, Okumura M.
    Cancer; 2002 Aug 01; 95(3):596-604. PubMed ID: 12209753
    [Abstract] [Full Text] [Related]

  • 8. Predictive factors for recurrence after percutaneous ethanol injection for solitary hepatocellular carcinoma.
    Ishii H, Okada S, Nose H, Okusaka T, Nagahama H, Nakayama H, Nakasuka H, Yoshimori M.
    Hepatogastroenterology; 1996 Aug 01; 43(10):938-43. PubMed ID: 8884317
    [Abstract] [Full Text] [Related]

  • 9. Prognosis of hepatocellular carcinoma with no tumor stain treated by percutaneous ethanol injection.
    Ueno H, Okada S, Okusaka T, Ikeda M, Tanaka N, Sakamoto M, Yoshimori M.
    Hepatogastroenterology; 2001 Aug 01; 48(41):1430-4. PubMed ID: 11677980
    [Abstract] [Full Text] [Related]

  • 10. Percutaneous ethanol injection therapy (PEIT) for hepatocellular carcinoma (HCC).
    Mueller PR.
    Jpn J Cancer Res; 1995 Nov 01; 86(11):inside front cover. PubMed ID: 8567388
    [No Abstract] [Full Text] [Related]

  • 11. Standards for selecting percutaneous ethanol injection therapy or percutaneous microwave coagulation therapy for solitary small hepatocellular carcinoma: consideration of local recurrence.
    Horigome H, Nomura T, Saso K, Itoh M.
    Am J Gastroenterol; 1999 Jul 01; 94(7):1914-7. PubMed ID: 10406259
    [Abstract] [Full Text] [Related]

  • 12. Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with non-resectable hepatocellular carcinoma.
    Dettmer A, Kirchhoff TD, Gebel M, Zender L, Malek NP, Panning B, Chavan A, Rosenthal H, Kubicka S, Krusche S, Merkesdal S, Galanski M, Manns MP, Bleck JS.
    World J Gastroenterol; 2006 Jun 21; 12(23):3707-15. PubMed ID: 16773687
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Carbon dioxide-enhanced sonographically guided percutaneous ethanol injection: treatment of patients with viable and recurrent hepatocellular carcinoma.
    Chen RC, Liao LY, Wang CS, Chen WT, Wang CK, Li YH, Tu HY, Chen PH.
    AJR Am J Roentgenol; 2003 Dec 21; 181(6):1647-52. PubMed ID: 14627590
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Power Doppler signals after percutaneous ethanol injection therapy for hepatocellular carcinoma predict local recurrence of tumors: a prospective study using 199 consecutive patients.
    Sato S, Shiratori Y, Imamura M, Teratani T, Obi S, Koike Y, Imai Y, Yoshida H, Shiina S, Omata M.
    J Hepatol; 2001 Aug 21; 35(2):225-34. PubMed ID: 11580145
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma.
    Ohnishi K, Yoshioka H, Ito S, Fujiwara K.
    Hepatology; 1998 Jan 21; 27(1):67-72. PubMed ID: 9425919
    [Abstract] [Full Text] [Related]

  • 20. Percutaneous ethanol injection therapy for recurrent hepatocellular carcinoma.
    Tanikawa K, Majima Y.
    Hepatogastroenterology; 1993 Aug 21; 40(4):324-7. PubMed ID: 8406300
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.